Estrella Immunopharma (ESLA) announced that the company has regained compliance with the listing requirements of Nasdaq. This confirmation follows the company’s efforts to improve its balance sheet, including raising new capital to continue development of its therapeutic candidates.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESLA: